ATE431130T1 - Verwendung einer äusseren rückschicht zur herstellung eines implantierbaren pflasters zur arzneistoffabgabe - Google Patents

Verwendung einer äusseren rückschicht zur herstellung eines implantierbaren pflasters zur arzneistoffabgabe

Info

Publication number
ATE431130T1
ATE431130T1 AT01973234T AT01973234T ATE431130T1 AT E431130 T1 ATE431130 T1 AT E431130T1 AT 01973234 T AT01973234 T AT 01973234T AT 01973234 T AT01973234 T AT 01973234T AT E431130 T1 ATE431130 T1 AT E431130T1
Authority
AT
Austria
Prior art keywords
drug
organ
produce
drug delivery
backing layer
Prior art date
Application number
AT01973234T
Other languages
English (en)
Inventor
Felix Theeuwes
Timothy Nelson
Original Assignee
Durect Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Durect Corp filed Critical Durect Corp
Application granted granted Critical
Publication of ATE431130T1 publication Critical patent/ATE431130T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01973234T 2000-09-22 2001-09-19 Verwendung einer äusseren rückschicht zur herstellung eines implantierbaren pflasters zur arzneistoffabgabe ATE431130T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/668,684 US6726920B1 (en) 2000-09-22 2000-09-22 Implantable drug delivery patch
PCT/US2001/029362 WO2002024159A2 (en) 2000-09-22 2001-09-19 Implantable drug delivery patch

Publications (1)

Publication Number Publication Date
ATE431130T1 true ATE431130T1 (de) 2009-05-15

Family

ID=24683338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01973234T ATE431130T1 (de) 2000-09-22 2001-09-19 Verwendung einer äusseren rückschicht zur herstellung eines implantierbaren pflasters zur arzneistoffabgabe

Country Status (8)

Country Link
US (1) US6726920B1 (de)
EP (1) EP1318786B1 (de)
AT (1) ATE431130T1 (de)
AU (1) AU2001292835A1 (de)
CA (1) CA2422859C (de)
DE (1) DE60138716D1 (de)
ES (1) ES2326071T3 (de)
WO (1) WO2002024159A2 (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7963997B2 (en) 2002-07-19 2011-06-21 Kensey Nash Corporation Device for regeneration of articular cartilage and other tissue
US8795242B2 (en) * 1994-05-13 2014-08-05 Kensey Nash Corporation Resorbable polymeric device for localized drug delivery
PT1420716E (pt) 2001-08-29 2012-11-21 Ricardo A P De Carvalho Um sistema implantável e selável destinado à administração unidireccional de agentes terapêuticos em tecidos-alvo
WO2012006095A1 (en) * 2010-06-28 2012-01-12 Hedman Thomas P Tissue crosslinking for treatment of snoring and obstructive sleep apnea
US6716158B2 (en) 2001-09-07 2004-04-06 Mardil, Inc. Method and apparatus for external stabilization of the heart
US7108685B2 (en) * 2002-04-15 2006-09-19 Boston Scientific Scimed, Inc. Patch stabilization of rods for treatment of cardiac muscle
WO2004033036A2 (en) * 2002-10-04 2004-04-22 Microchips, Inc. Medical device for controlled drug delivery and cardiac monitoring and/or stimulation
EP1651197A1 (de) 2003-07-28 2006-05-03 ALZA Corporation Transdermales warfarin enthaltendes abgabesystem
US20050107867A1 (en) * 2003-11-17 2005-05-19 Taheri Syde A. Temporary absorbable venous occlusive stent and superficial vein treatment method
US8019437B2 (en) * 2004-02-05 2011-09-13 Medtronic, Inc. Lead fixation means
US7402320B2 (en) * 2004-08-31 2008-07-22 Vnus Medical Technologies, Inc. Apparatus, material compositions, and methods for permanent occlusion of a hollow anatomical structure
GB2421431B (en) * 2004-12-24 2007-10-10 Aquasol Ltd Dosing systems
WO2006081238A2 (en) * 2005-01-25 2006-08-03 Vnus Medical Technologies, Inc. Structures for permanent occlusion of a hollow anatomical structure
US7785291B2 (en) * 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
WO2006110889A2 (en) * 2005-04-11 2006-10-19 The Board Of Trustees Of The Leland Stanford Junior University Multi-layer structure having a predetermined layer pattern including an agent
CA2609456C (en) * 2005-05-25 2014-04-29 Massachusetts Institute Of Technology Localized delivery of cardiac inotropic agents
CA2618807C (en) * 2005-08-12 2015-01-06 University Health Network Methods and devices for lymphatic targeting
US20070156113A1 (en) * 2006-01-03 2007-07-05 Heartcor Organ shealth for percutaneous delivery of biological and pharmacological agents
US20070208217A1 (en) 2006-03-03 2007-09-06 Acorn Cardiovascular, Inc. Self-adjusting attachment structure for a cardiac support device
US9017361B2 (en) * 2006-04-20 2015-04-28 Covidien Lp Occlusive implant and methods for hollow anatomical structure
US7833284B2 (en) * 2006-06-28 2010-11-16 The Cleveland Clinic Foundation Anti-adhesion membrane
US7908017B1 (en) 2006-08-28 2011-03-15 Pacesetter, Inc. Lead deployable myocardial infarction patch
US8029532B2 (en) * 2006-10-11 2011-10-04 Cook Medical Technologies Llc Closure device with biomaterial patches
US20080167592A1 (en) * 2006-10-26 2008-07-10 Greer Steven E Preventing or treating wounds with a collodion barrier incorporating active agents
WO2009020607A2 (en) * 2007-08-07 2009-02-12 Arsenal Medical, Inc. Method and apparatus for composite drug delivery medical devices
US8092363B2 (en) * 2007-09-05 2012-01-10 Mardil, Inc. Heart band with fillable chambers to modify heart valve function
WO2009038792A2 (en) * 2007-09-17 2009-03-26 The Board Of Trustees Of The Leland Stanford Junior University Polymer devices for therapeutic applications
US20090181068A1 (en) 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9095404B2 (en) 2008-05-12 2015-08-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
WO2009140246A2 (en) * 2008-05-12 2009-11-19 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US20090304776A1 (en) * 2008-06-06 2009-12-10 Totada Shantha Transmucosal delivery of therapeutic agents and methods of use thereof
WO2010027851A1 (en) * 2008-08-26 2010-03-11 Massachusetts Institute Of Technology Devices and systems for local delivery of inotropic agents to the epicardium
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
CA2737461A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care, Inc. Solute concentration measurement device and related methods
US8324178B2 (en) * 2008-10-31 2012-12-04 The Regents Of The University Of California Method of treatment using alpha-1-adrenergic agonist compounds
US9161903B2 (en) * 2008-10-31 2015-10-20 Warsaw Orthopedic, Inc. Flowable composition that hardens on delivery to a target tissue site beneath the skin
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US9008765B2 (en) 2009-02-12 2015-04-14 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US20110152770A1 (en) 2009-07-30 2011-06-23 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
WO2011044175A2 (en) 2009-10-06 2011-04-14 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
WO2011100376A2 (en) 2010-02-10 2011-08-18 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
AU2012230701B2 (en) 2011-03-24 2016-09-29 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents
ES2644138T3 (es) 2011-06-13 2017-11-27 Rival S.E.C N,N,N-trialquilpolímeros, métodos para su preparación y usos de los mismos
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US10507127B2 (en) 2012-06-07 2019-12-17 Epitomee Medical Ltd. Expandable device
US9311201B2 (en) 2012-08-22 2016-04-12 International Business Machines Corporation Real-time rule engine for adaptive testing of integrated circuits
US20140100530A1 (en) * 2012-10-05 2014-04-10 Miguel A. Linares Attachable uterine device with integrated and time release medicinal administering component and insertion tool for implanting such a device
US9370425B2 (en) 2012-10-12 2016-06-21 Mardil, Inc. Cardiac treatment system and method
US9364462B2 (en) 2012-10-30 2016-06-14 The Regents Of The University Of California Alpha-1-adrenergic receptor agonist therapy
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
USD717954S1 (en) 2013-10-14 2014-11-18 Mardil, Inc. Heart treatment device
CN105899198A (zh) 2013-12-05 2016-08-24 图利普医疗有限公司 用于药物活性试剂的原位释放的滞留装置和系统
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
KR102557319B1 (ko) 2015-03-30 2023-07-18 타리스 바이오메디컬 엘엘씨 상부 요로로의 약물의 국부적인 전달을 위한 장치 및 방법
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
WO2019023617A1 (en) 2017-07-27 2019-01-31 University Of Utah Research Foundation DEVICE FOR DELIVERY OF THERAPEUTIC PRODUCT
EP3476385B1 (de) 2017-10-27 2023-11-29 AdjuCor GmbH Zusammenklappbarer myokard-patch
GB202211580D0 (en) * 2022-08-09 2022-09-21 Cambridge Entpr Ltd Implantable device

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144317A (en) 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
JPS60174716A (ja) 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤
US4597961A (en) 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
US5387419A (en) * 1988-03-31 1995-02-07 The University Of Michigan System for controlled release of antiarrhythmic agents
US5087243A (en) * 1990-06-18 1992-02-11 Boaz Avitall Myocardial iontophoresis
US5292362A (en) 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5681278A (en) 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
US5827216A (en) 1995-06-07 1998-10-27 Cormedics Corp. Method and apparatus for accessing the pericardial space
US5985312A (en) 1996-01-26 1999-11-16 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US5827530A (en) 1996-02-05 1998-10-27 Reed, Jr.; Fred Dewitt Fillable patch for dermal or transdermal delivery
US5931810A (en) 1996-12-05 1999-08-03 Comedicus Incorporated Method for accessing the pericardial space
US5906997A (en) 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US5972013A (en) 1997-09-19 1999-10-26 Comedicus Incorporated Direct pericardial access device with deflecting mechanism and method

Also Published As

Publication number Publication date
CA2422859A1 (en) 2002-03-28
AU2001292835A1 (en) 2002-04-02
EP1318786B1 (de) 2009-05-13
EP1318786A2 (de) 2003-06-18
ES2326071T3 (es) 2009-09-30
DE60138716D1 (de) 2009-06-25
US6726920B1 (en) 2004-04-27
CA2422859C (en) 2010-03-30
WO2002024159A2 (en) 2002-03-28
WO2002024159A3 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
ATE431130T1 (de) Verwendung einer äusseren rückschicht zur herstellung eines implantierbaren pflasters zur arzneistoffabgabe
ATE554804T1 (de) Verfahren zur herstellung von beschichteten medizinischen vorrichtungen
ATE466604T1 (de) Medizinische vorrichtung zur verabreichung therapeutischer wirkstoffe über unterschiedliche zeitabschnitte
DE602007002490D1 (de) Verfahren zur herstellung eines geräts mit einer gelschicht
ATE502663T1 (de) Medizinische vorrichtungen mit einem porösen metalloxid- oder metallmaterial und einer polymerbeschichtung zur freisetzung von therapeutika
DE69923675D1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
EP1681003A3 (de) Lösliche Tücher für die Aufbringung einer Lösung auf eine Oberfläche
DE60041196D1 (de) Vorrichtung zur abgabe von wirkstoffen im gewebe eines lebenden körpers
DE602005013405D1 (de) Stents mit wirkstofffreisetzungsbeschichtungen
DE50110168D1 (de) Transdermales therapeutisches system zur abgabe von venlafaxin
EA201170297A1 (ru) Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
ATE253912T1 (de) Verwendung von nikotinergen acetylcholinrezeptor- agonisten zur herstellung eines medikaments zur behandlung von keratoconjuctivitis sicca
ATE229322T1 (de) Pharmazeutisches trägermittel, geeignet zur applikation pharmazeutischer verbindungen auf mucosale öberflächen
ATE483493T1 (de) Medizinische vorrichtung
BRPI0508678A (pt) emplastro para provisão de terapia a um indivìduo, método para provisão de terapia a um indivìduo e método de fabricação de um emplatro que provê terapia a um indivìduo
FR2808478B1 (fr) Moyen de securisation d'un substrat
ATE529101T1 (de) Pflaster zur anwendung auf der haut
ATE456391T1 (de) Abgabe eines therapeutischen mittels
AR050621A1 (es) Sistema terapeutico transdermal con una capa adherente procedimiento para el siliconado de una capa de respaldo y empleo de la capa de respaldo
ATE381952T1 (de) Ballon mit verbesserter retention
ATE517616T1 (de) Faserfreies transdermales therapeutisches system und verfahren zu seiner herstellung
PL1638535T3 (pl) Podskórne implanty o ograniczonym początkowym uwalnianiu składnika czynnego, a następnie o rozciągniętym w czasie uwalnianiu zmieniającym się liniowo
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
MXPA04003596A (es) Dispositivo de liberacion de substancias.
DE60214145D1 (de) An einer rückschicht gebundenes hydrogel und verfahren zur herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties